Stay updated on LDX Safety in Children & Adolescents Clinical Trial
Sign up to get notified when there's something new on the LDX Safety in Children & Adolescents Clinical Trial page.

Latest updates to the LDX Safety in Children & Adolescents Clinical Trial page
- Check5 days agoChange DetectedThe revision label in the page footer has updated from v3.3.1 to v3.3.2; substantive content and study details remain unchanged, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoChange DetectedAn editorial note that publications are automatically filled from PubMed was added, and the older PubMed-based description was removed; the revision identifier was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check19 days agoChange DetectedThe general NIH operating-status banner about funding lapses was removed from the page. This banner did not affect study details or data.SummaryDifference0.3%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page content appears largely unchanged between the two screenshots, with only minor formatting differences and no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedUpdate to a newer revision identifier (v3.2.0) replaces the older v3.0.2.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page update indicates a shift from revision v3.0.2 to v3.1.0, updating the version identifier.SummaryDifference0.1%

Stay in the know with updates to LDX Safety in Children & Adolescents Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LDX Safety in Children & Adolescents Clinical Trial page.